We’re pleased to participate in this year’s Spring Meeting
Join us in Washington, DC, from April 2 - 4 for the American Bar Association’s annual Spring Meeting. Several attorneys from Axinn will be moderating and speaking on a range of panels, providing valuable insights on relevant industry topics. We’re also honored to have been nominated for multiple awards at the GCR and Antitrust Writing Awards, both of which will take place the same week.
Attend Thought-Provoking Panels
As agency investigations and new merger guidelines continue to focus antitrust on the pharmaceutical ecosystem, panelists will discuss legal and economic aspects of newer, less explored antitrust theories such as alleged harm from reduced innovation, bundled rebates, inappropriate patent listings, and self-preferencing PBM practices.
The FTC, DOJ, European Commission, and CMA have focused on monopolists’ exclusionary tactics such as “moat-building” and entrenchment. Panelists will discuss recent enforcement actions to understand the trends in U.S., EU, and UK approach to monopoly entrenchment and moat-building.
Many believe that the U.S. economy has suffered from widespread decline in competitiveness, measured by increasing concentration or markups. Panelists will discuss what the empirical evidence shows, and what the implications are for antitrust policy.
What Sets Us Apart
- Our 70+ full-time antitrust lawyers represent the world’s biggest corporations, including many of the Fortune 500
- Our track record of obtaining global clearance of combinations of significant rivals has built Axinn’s reputation as a “go-to” firm for strategic mergers and acquisitions
- We are lead defense counsel to some of the world’s largest companies in high-stakes treble damages, class action, and multi-district litigations, as well as federal and state investigations
- Our lawyers have defended companies and individuals in the largest price-fixing investigations of the last decade, and include former federal prosecutors and Antitrust Division leaders overseeing the Division’s criminal investigations, trials, and policy
- We combine our extensive experience before antitrust agencies around the world with our strategic agility and the ability to develop and present sophisticated econometric arguments
- Our team includes a broad range of experience in government, in-house, and private practice, ensuring a comprehensive, multifaceted, and bespoke approach to our clients’ needs
Antitrust Law in Action: Transactions, Litigation, and Cartels
High-Stakes Experience
Select Honors
Explore Our Other Practices
Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
Featured Axinn Viewpoints
Featured Axinn Viewpoints
Passing the Laboring Oar? What’s to Come for No-Poach and Wage-Fixing Prosecutions
Axinn at the 2025 ABA White Collar Crime Conference
Key Questions for Navigating the Changing Competition Landscape in the Nordics and EU
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump
Growing Role of Texas In Driving US Antitrust Policy
Antitrust Enforcement in Energy M&A in the Trump Era — 4 Issues to Watch
The Goods on Antitrust & Consumer Packaged Goods: A Sneak Preview of Axinn’s Thoughts in Advance of the CPG Legal Forum
Competition Law Developments in Germany: Three Things We Are Watching
Who’s Blocking Me? Competition Law Issues With Healthcare Information Blocking
2023 Merger Guidelines Continue in Effect
